News

28 Mar 2025

New research from Lund University may expand the donor lung pool for transplantation

A new scientific publication from Professor Sandra Lindstedt and her research team at Lund University highlights innovative strategies to improve lung transplantation through an in-depth analysis of molecular and functional responses to different types of lung injury. The study, recently published in Transplantation, explores how three distinct models of lung injury affect donor lungs and…

Read more
05 Mar 2025

PExA strengthens IP portfolio with European Patent Office’s “Intention to Grant” for non-invasive analysis of small airway particles during medical ventilation

PExA AB today announced that the European Patent Office (EPO) has issued an “Intention to Grant” for the company’s patent application covering its pioneering solution for non-invasive analysis of small airway particles in ventilated patients. This patent covers a device and method for analyzing exhaled particles to assess lung function during mechanical ventilation. The solution…

Read more
04 Feb 2025

Rising lung cancer rates among non-smokers highlight the need for early detection

On World Cancer Day, an article in The Guardian highlights the increasing incidence of lung cancer among people who have never smoked, with a particularly notable rise among women. Lung cancer remains the most common cancer globally and the leading cause of cancer-related mortality. While smoking-related lung cancer has declined as smoking rates have decreased in countries…

Read more
15 Jan 2025

New study highlights PExA’s potential as a novel method for non-invasive measurement of drug levels in the lung

A new study published in the Journal of Aerosol Medicine and Pulmonary Drug Delivery showcases a potential breakthrough in lung pharmacokinetics (PK) research using the PExA® instrument developed by PExA AB. The study, titled “Assessing human lung pharmacokinetics using exhaled breath particles,” demonstrates the feasibility of utilizing exhaled breath particles (PEx) for non-invasive measurement of…

Read more
20 Dec 2024

Season’s greetings from PExA – advancing lung disease research and diagnostics together!

As we reflect on the past year and look ahead to new possibilities, we want to extend our heartfelt thanks to our valued customers, partners and stakeholders. Your continued support empowers our mission to transform lung disease research and diagnostics with pioneering non-invasive technology. How PExA works: PExA’s solution collects and analyzes microscopic particles from…

Read more

Archive

Categories